Upgrades:
Bank of Montreal (NYSE:BMO) (TSE:BMO) was upgraded by analysts at Barclays from an "underweight" rating to an "equal weight" rating in a research note issued to investors on Tuesday, Briefing.com reports.
Other analysts have also issued research reports about the
stock. Credit Suisse Group raised their price objective on shares of Bank of
Montreal from $138.00 to $144.00 and gave the stock an "outperform"
rating in a report on Wednesday, August 25th. CIBC raised their price objective
on shares of Bank of Montreal from $139.00 to $148.00 and gave the stock an
"outperformer" rating in a report on Wednesday, August 25th.
Canaccord Genuity raised their price objective on shares of Bank of Montreal from
C$143.00 to C$149.00 and gave the stock a "buy" rating in a report on
Wednesday, August 25th. BMO Capital Markets raised their price objective on
shares of Bank of Montreal from C$150.00 to C$152.00 and gave the stock a
"buy" rating in a report on Wednesday, August 25th. Finally,
Desjardins raised their price objective on shares of Bank of Montreal from
C$133.00 to C$138.00 and gave the stock a "hold" rating in a report
on Thursday, August 26th. Four analysts have rated the stock with a hold rating
and seven have given a buy rating to the company's stock. According to data
from MarketBeat, the company currently has a consensus rating of
"Buy" and a consensus target price of $142.27. Read
more …
The Southern (NYSE:SO) was upgraded by analysts at Guggenheim from a "neutral" rating to a "buy" rating in a research note issued on Tuesday, The Fly reports.
Other analysts also recently issued reports about the
company. Wells Fargo & Company reaffirmed a "buy" rating on
shares of The Southern in a report on Monday, August 2nd. Morgan Stanley
boosted their target price on The Southern from $60.00 to $64.00 and gave the
company an "underweight" rating in a report on Thursday, August 19th.
Barclays boosted their target price on The Southern from $70.00 to $76.00 and
gave the company an "overweight" rating in a report on Tuesday, May
25th. Credit Suisse Group reissued a "buy" rating on shares of The
Southern in a report on Wednesday, May 19th. Finally, Mizuho boosted their
target price on The Southern from $57.00 to $60.00 and gave the company an
"underperform" rating in a report on Monday, August 30th. Three
analysts have rated the stock with a sell rating, one has issued a hold rating
and nine have assigned a buy rating to the company's stock. Based on data from
MarketBeat, the company has an average rating of "Hold" and an
average price target of $68.42. Read
more …
The Toronto-Dominion Bank (NYSE:TD) (TSE:TD) was upgraded by stock analysts at Barclays from an “equal weight” rating to an “overweight” rating in a note issued to investors on Tuesday, The Fly reports.
TD has been the topic of several other reports. Zacks
Investment Research cut The Toronto-Dominion Bank from a “hold” rating to a
“sell” rating in a research note on Tuesday. BMO Capital Markets reduced their
price objective on The Toronto-Dominion Bank from C$96.00 to C$94.00 and set a
“market perform” rating on the stock in a research note on Friday, August 27th.
Finally, Scotiabank reduced their price objective on The Toronto-Dominion Bank
from C$95.00 to C$94.00 in a research note on Tuesday, August 17th. Four
analysts have rated the stock with a sell rating, four have given a hold rating
and two have assigned a buy rating to the company. Based on data from MarketBeat,
the stock presently has an average rating of “Hold” and a consensus target
price of $80.60. Read
more …
Ventas (NYSE:VTR) was upgraded by Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a research report issued on Tuesday, The Fly reports.
Several other equities analysts also recently commented on
the stock. Royal Bank of Canada upped their price target on shares of Ventas
from $62.00 to $65.00 and gave the company an "outperform" rating in
a report on Wednesday, June 30th. Wolfe Research began coverage on shares of
Ventas in a research note on Monday, June 14th. They issued an
"outperform" rating and a $71.00 target price on the stock. BMO
Capital Markets upgraded shares of Ventas from an "underperform"
rating to a "market perform" rating and set a $60.00 target price on
the stock in a research note on Thursday, August 26th. Robert W. Baird upgraded
shares of Ventas from a "neutral" rating to an "outperform"
rating and set a $58.00 target price on the stock in a research note on Thursday,
May 13th. Finally, Scotiabank upped their target price on shares of Ventas from
$61.00 to $63.00 and gave the stock a "sector perform" rating in a
research note on Thursday, July 1st. Eight equities research analysts have
rated the stock with a hold rating and seven have assigned a buy rating to the
company. Based on data from MarketBeat, the stock has a consensus rating of
"Hold" and a consensus price target of $58.41. Read
more …
Apple (NASDAQ:AAPL) was upgraded by research analysts at Robert W. Baird to an "outperform" rating in a note issued to investors on Wednesday, The Fly reports. The brokerage presently has a $170.00 price objective on the iPhone maker's stock, up from their previous price objective of $160.00. Robert W. Baird's price objective would suggest a potential upside of 8.49% from the stock's current price.
Several other equities analysts also recently weighed in on
AAPL. Fundamental Research raised their target price on shares of Apple from
$144.27 to $163.99 and gave the company a "buy" rating in a report on
Tuesday, August 31st. Evercore ISI lifted their price target on shares of Apple
from $175.00 to $180.00 and gave the stock an "outperform" rating in
a report on Wednesday, July 28th. UBS Group set a $175.00 target price on
shares of Apple in a report on Monday, August 30th. DA Davidson boosted their
target price on shares of Apple from $167.00 to $175.00 and gave the company a
"buy" rating in a report on Wednesday, July 28th. Finally, New Street
Research cut shares of Apple from a "neutral" rating to a
"sell" rating and set a $90.00 price target on the stock. in a
research report on Friday, May 28th. One analyst has rated the stock with a
sell rating, seven have assigned a hold rating and twenty-six have issued a buy
rating to the stock. According to data from MarketBeat.com, the company
presently has a consensus rating of "Buy" and a consensus target
price of $158.08. Read
more …
Albemarle (NYSE:ALB) was upgraded by equities research analysts at Berenberg Bank from a “sell” rating to a “buy” rating in a research report issued on Wednesday, The Fly reports. The firm presently has a $280.00 price objective on the specialty chemicals company’s stock, up from their prior price objective of $115.00. Berenberg Bank’s target price points to a potential upside of 17.26% from the stock’s previous close.
ALB has been the subject of a number of other reports. Cowen
boosted their target price on Albemarle from $180.00 to $260.00 and gave the
company an “outperform” rating in a research report on Monday, August 30th.
Bank of America boosted their target price on Albemarle from $121.00 to $140.00
and gave the stock an “underperform” rating in a research note on Friday,
August 6th. They noted that the move was a valuation call. Deutsche Bank
Aktiengesellschaft boosted their target price on Albemarle from $190.00 to
$245.00 and gave the stock a “buy” rating in a research note on Friday, August
6th. BMO Capital Markets boosted their target price on Albemarle from $205.00
to $250.00 and gave the stock an “outperform” rating in a research note on
Friday, August 6th. Finally, Zacks Investment Research upgraded Albemarle from
a “hold” rating to a “buy” rating and set a $197.00 target price on the stock
in a research note on Tuesday, July 13th. Three investment analysts have rated the
stock with a sell rating, six have given a hold rating and eleven have issued a
buy rating to the company. Based on data from MarketBeat, the company currently
has an average rating of “Hold” and a consensus price target of $180.43. Read
more …
Downgrades:
Amgen (NASDAQ:AMGN) was downgraded by equities researchers at Morgan Stanley from an "overweight" rating to an "equal weight" rating in a report released on Tuesday, The Fly reports. They presently have a $251.00 price target on the medical research company's stock, down from their prior price target of $280.00. Morgan Stanley's price target suggests a potential upside of 10.88% from the stock's previous close.
Several other analysts also recently weighed in on the
stock. Zacks Investment Research upgraded shares of Amgen from a "sell"
rating to a "hold" rating and set a $255.00 price objective on the
stock in a research report on Tuesday, June 29th. Robert W. Baird reiterated a
"sell" rating on shares of Amgen in a research report on Thursday,
August 5th. SVB Leerink cut their price objective on shares of Amgen from
$238.00 to $234.00 and set a "market perform" rating on the stock in
a research report on Wednesday, August 4th. Mizuho reiterated a
"hold" rating and issued a $200.00 price objective on shares of Amgen
in a research report on Friday, June 25th. Finally, Oppenheimer lifted their
price objective on shares of Amgen from $272.00 to $277.00 and gave the company
an "outperform" rating in a research report on Monday, June 7th. Two
equities research analysts have rated the stock with a sell rating, ten have
assigned a hold rating and eleven have given a buy rating to the company. Based
on data from MarketBeat.com, Amgen presently has an average rating of
"Hold" and a consensus target price of $248.60. Read
more …
Johnson & Johnson (NYSE:JNJ) was downgraded by Morgan Stanley from an "overweight" rating to an "equal weight" rating in a research report issued on Tuesday, The Fly reports. They currently have a $187.00 price objective on the stock. Morgan Stanley's target price would indicate a potential upside of 6.83% from the stock's previous close.
Several other equities analysts have also recently commented
on the stock. SVB Leerink reissued a "buy" rating on shares of
Johnson & Johnson in a research note on Thursday, July 29th. Credit Suisse Group
set a $193.00 target price on shares of Johnson & Johnson and gave the
company a "buy" rating in a research note on Monday, June 7th. Two
research analysts have rated the stock with a hold rating and six have issued a
buy rating to the stock. According to data from MarketBeat, the stock has a
consensus rating of "Buy" and a consensus target price of $190.38.
Shares of NYSE:JNJ opened at $175.04 on Tuesday. The company
has a market cap of $460.79 billion, a PE ratio of 26.32, a P/E/G ratio of 2.34
and a beta of 0.71. The company has a quick ratio of 1.13, a current ratio of
1.39 and a debt-to-equity ratio of 0.44. The company's 50-day moving average
price is $172.27 and its 200 day moving average price is $166.90. Johnson &
Johnson has a fifty-two week low of $133.65 and a fifty-two week high of
$179.92. Read
more …
Merck & Co., Inc. (NYSE:MRK) was downgraded by research analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a research report issued to clients and investors on Tuesday, The Fly reports.
A number of other analysts have also commented on the
company. Truist Securities started coverage on Merck & Co., Inc. in a
report on Tuesday, July 27th. They set a “buy” rating and a $76.79 price
objective for the company. SVB Leerink upped their target price on Merck &
Co., Inc. from $99.00 to $101.00 and gave the company an “outperform” rating in
a report on Friday, July 30th. JPMorgan Chase & Co. reduced their target
price on Merck & Co., Inc. from $105.00 to $100.00 and set an “overweight”
rating for the company in a report on Wednesday, June 9th. Argus restated a
“hold” rating on shares of Merck & Co., Inc. in a research report on
Thursday, May 20th. Finally, Zacks Investment Research upgraded Merck &
Co., Inc. from a “sell” rating to a “hold” rating and set a $82.00 price
objective on the stock in a research report on Tuesday, August 24th. Four
investment analysts have rated the stock with a hold rating and seven have
assigned a buy rating to the company. Based on data from MarketBeat, Merck
& Co., Inc. currently has an average rating of “Buy” and an average price
target of $91.85. Read
more …
Shaw Communications (NYSE:SJR) (TSE:SJR.B) was downgraded by analysts at Canaccord Genuity from a "buy" rating to a "hold" rating in a research note issued on Tuesday, Briefing.com reports.
Separately, Zacks Investment Research downgraded Shaw
Communications from a "buy" rating to a "hold" rating and
set a $31.00 price target for the company. in a research report on Friday, June
4th. Six investment analysts have rated the stock with a hold rating and three
have assigned a buy rating to the company's stock. According to data from
MarketBeat.com, the company presently has an average rating of "Hold"
and an average target price of $33.36.
SJR stock opened at $29.75 on Tuesday. The firm has a fifty
day moving average price of $29.03 and a 200 day moving average price of
$27.52. Shaw Communications has a fifty-two week low of $16.12 and a fifty-two
week high of $30.41. The company has a debt-to-equity ratio of 0.77, a quick
ratio of 0.76 and a current ratio of 0.80. The firm has a market cap of $14.18
billion, a PE ratio of 21.25 and a beta of 0.71. Read
more …
Cisco Systems (NASDAQ:CSCO) was downgraded by research analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating in a report issued on Thursday, The Fly reports. They presently have a $59.00 price target on the network equipment provider’s stock, up from their previous price target of $57.00. Morgan Stanley’s price target indicates a potential upside of 0.55% from the company’s current price.
Other equities analysts also recently issued reports about
the company. DZ Bank reiterated a “hold” rating and issued a $51.00 target
price on shares of Cisco Systems in a research report on Thursday, May 27th.
Piper Sandler increased their target price on Cisco Systems from $49.00 to
$53.00 and gave the company a “neutral” rating in a research report on
Thursday, August 19th. Barclays increased their target price on Cisco Systems
from $55.00 to $62.00 and gave the company an “overweight” rating in a research
report on Thursday, August 19th. They noted that the move was a valuation call.
Deutsche Bank Aktiengesellschaft increased their target price on Cisco Systems
from $55.00 to $59.00 and gave the company a “hold” rating in a research report
on Tuesday, August 24th. Finally, MKM Partners started coverage on Cisco
Systems in a research report on Thursday, May 13th. They issued a “buy” rating
and a $61.00 target price for the company. Eleven analysts have rated the stock
with a hold rating and ten have issued a buy rating to the stock. Based on data
from MarketBeat.com, the company has a consensus rating of “Hold” and an
average target price of $54.90. Read
more …
Devon Energy (NYSE:DVN) was downgraded by analysts at The Goldman Sachs Group from a "conviction-buy" rating to a "buy" rating in a research note issued on Thursday, The Fly reports.
DVN has been the topic of a number of other reports. Wells
Fargo & Company increased their price objective on shares of Devon Energy from
$37.00 to $38.00 and gave the stock an "overweight" rating in a
research note on Monday, August 23rd. Piper Sandler raised their price target
on shares of Devon Energy from $34.00 to $37.00 and gave the company an
"overweight" rating in a research note on Thursday, July 22nd. Mizuho
raised their price target on shares of Devon Energy from $35.00 to $38.00 and
gave the company a "buy" rating in a research note on Thursday, July
15th. Morgan Stanley raised their price target on shares of Devon Energy from
$32.00 to $34.00 and gave the company an "equal weight" rating in a
research note on Monday, August 23rd. Finally, Barclays raised their price
target on shares of Devon Energy from $27.00 to $35.00 and gave the company an
"overweight" rating in a research note on Thursday, June 3rd. Three
analysts have rated the stock with a hold rating, eighteen have issued a buy
rating and one has given a strong buy rating to the stock. Based on data from
MarketBeat.com, Devon Energy has a consensus rating of "Buy" and an
average target price of $30.25. Read
more …
PPG Industries (NYSE:PPG) was downgraded by investment analysts at Citigroup from a “buy” rating to a “neutral” rating in a research report issued to clients and investors on Thursday, The Fly reports.
PPG has been the topic of several other reports. BMO Capital
Markets cut their target price on PPG Industries from $197.00 to $189.00 and
set an “outperform” rating on the stock in a report on Wednesday, July 21st.
Deutsche Bank Aktiengesellschaft lowered their price target on PPG Industries
from $190.00 to $185.00 and set a “buy” rating on the stock in a research
report on Wednesday. Societe Generale lifted their target price on PPG
Industries from $168.00 to $192.00 and gave the stock a “buy” rating in a
research report on Thursday, July 1st. Susquehanna raised PPG Industries from a
“neutral” rating to a “positive” rating and lifted their target price for the
stock from $115.00 to $190.00 in a research report on Monday, July 26th.
Finally, Wells Fargo & Company decreased their price objective on PPG
Industries from $187.00 to $180.00 and set an “overweight” rating on the stock
in a report on Wednesday. Five investment analysts have rated the stock with a
hold rating and sixteen have given a buy rating to the company. According to
data from MarketBeat, the company currently has an average rating of “Buy” and
an average target price of $172.02. Read
more …
The Sherwin-Williams (NYSE:SHW) was downgraded by equities researchers at Citigroup from a “buy” rating to a “neutral” rating in a research report issued on Thursday, The Fly reports.
Several other analysts have also issued reports on SHW.
Royal Bank of Canada upped their target price on shares of The Sherwin-Williams
from $324.00 to $327.00 and gave the stock an “outperform” rating in a research
note on Wednesday, June 9th. Barclays boosted their price target on shares of
The Sherwin-Williams from $299.00 to $305.00 and gave the stock an “equal
weight” rating in a report on Wednesday, July 28th. Deutsche Bank
Aktiengesellschaft boosted their price target on shares of The Sherwin-Williams
from $315.00 to $320.00 and gave the stock a “buy” rating in a report on
Wednesday, July 28th. Loop Capital boosted their price target on shares of The
Sherwin-Williams from $300.00 to $310.00 and gave the stock a “buy” rating in a
report on Wednesday, June 9th. Finally, Robert W. Baird reissued a “buy” rating
and issued a $325.00 price target on shares of The Sherwin-Williams in a report
on Wednesday, July 28th. Four equities research analysts have rated the stock
with a hold rating and sixteen have assigned a buy rating to the company’s
stock. According to data from MarketBeat, the stock has an average rating of
“Buy” and a consensus target price of $327.96. Read
more …
American Tower (NYSE:AMT) was downgraded by equities research analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a note issued to investors on Friday, Price Targets.com reports. They currently have a $300.00 price target on the real estate investment trust’s stock, down from their prior price target of $305.00. Oppenheimer’s price objective indicates a potential upside of 2.20% from the company’s previous close.
Several other research firms have also issued reports on
AMT. Argus lifted their price target on American Tower from $288.00 to $300.00
and gave the stock a “buy” rating in a research report on Thursday, August
12th. Credit Suisse Group upped their price objective on American Tower from
$314.00 to $323.00 and gave the stock an “outperform” rating in a report on Friday,
July 30th. Truist increased their price target on American Tower from $280.00
to $315.00 and gave the company a “buy” rating in a report on Friday, July
30th. Truist Securities upped their price objective on American Tower from
$280.00 to $315.00 and gave the company a “buy” rating in a research report on
Friday, July 30th. Finally, Wells Fargo & Company increased their price
target on American Tower from $280.00 to $305.00 and gave the stock an
“overweight” rating in a research report on Friday, July 16th. Five research
analysts have rated the stock with a hold rating and eleven have issued a buy
rating to the company’s stock. Based on data from MarketBeat.com, the stock
presently has a consensus rating of “Buy” and a consensus price target of
$298.06. Read
more …
Crown Castle International (NYSE:CCI) was downgraded by analysts at Oppenheimer from an “outperform” rating to a “market perform” rating in a research note issued to investors on Friday, The Fly reports.
A number of other brokerages have also weighed in on CCI.
KeyCorp lifted their price target on shares of Crown Castle International from
$207.00 to $224.00 and gave the company an “overweight” rating in a research
note on Monday, July 19th. They noted that the move was a valuation call.
Credit Suisse Group cut their price objective on shares of Crown Castle
International from $193.00 to $192.00 and set a “neutral” rating on the stock
in a research report on Friday, July 23rd. Deutsche Bank Aktiengesellschaft
boosted their price objective on shares of Crown Castle International from
$195.00 to $209.00 and gave the stock a “buy” rating in a research report on
Friday, June 11th. Morgan Stanley raised shares of Crown Castle International
from an “in-line” rating to an “overweight” rating and boosted their price objective
for the stock from $200.00 to $204.00 in a research report on Wednesday, June
2nd. Finally, Citigroup downgraded shares of Crown Castle International from a
“buy” rating to a “neutral” rating in a report on Tuesday, July 13th. Five
equities research analysts have rated the stock with a hold rating and eight
have given a buy rating to the company. According to MarketBeat.com, the stock
has a consensus rating of “Buy” and a consensus target price of $194.00. Read
more …
Freeport-McMoRan (NYSE:FCX) was downgraded by analysts at Credit Suisse Group from a "neutral" rating to an "underperform" rating in a report released on Friday, The Fly reports.
A number of other research analysts also recently weighed in
on FCX. Royal Bank of Canada upped their target price on Freeport-McMoRan from
$39.00 to $42.00 and gave the stock a "sector perform" rating in a
report on Friday, July 23rd. Exane BNP Paribas downgraded Freeport-McMoRan from
an "outperform" rating to a "neutral" rating in a report on
Friday, June 4th. BNP Paribas downgraded Freeport-McMoRan from an
"outperform" rating to a "neutral" rating and set a $40.30
target price on the stock. in a report on Friday, June 4th. Jefferies Financial
Group upped their target price on Freeport-McMoRan to $60.00 and gave the stock
a "buy" rating in a report on Monday, May 17th. Finally, Deutsche
Bank Aktiengesellschaft reduced their target price on Freeport-McMoRan from
$50.00 to $47.00 and set a "buy" rating on the stock in a report on
Friday, July 23rd. Three research analysts have rated the stock with a sell
rating, five have assigned a hold rating, eight have assigned a buy rating and
one has issued a strong buy rating to the company. According to MarketBeat, the
stock has a consensus rating of "Hold" and an average target price of
$37.99.
FCX opened at $34.81 on Friday. The business has a 50 day
simple moving average of $35.78 and a two-hundred day simple moving average of
$37.01. The firm has a market capitalization of $51.10 billion, a
price-to-earnings ratio of 18.23 and a beta of 2.08. The company has a
debt-to-equity ratio of 0.41, a current ratio of 2.28 and a quick ratio of
1.52. Freeport-McMoRan has a one year low of $14.67 and a one year high of
$46.10. Read
more …
Comments
Post a Comment